Sean Doherty ^Investor

Sean Doherty is a seasoned leader with a background in law, finance, and philanthropy. As the Founder and Chair of the JDRF T1D Fund, he has driven significant investments in disease-modifying therapies for Type 1 Diabetes. His role as a Board Member at Provention Bio and IM Therapeutics showcases his commitment to advancing autoimmune disease treatments. With a J.D. magna cum laude from Harvard Law School and a B.A. magna cum laude in Government from Harvard University, Sean brings a wealth of knowledge and experience to his work in amplifying the voices of patients and caregivers in the T1D community.